Risdiplam is a chemical compound used as an active pharmaceutical ingredient in the manufacturing of oral medications for spinal muscular atrophy. It was the first oral medication approved by the US FDA for this condition.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1825352-65-5
Ravuconazole
pharmaceutical raw material
Tert-Butyl {(2S,3R)-4-[(4-aminobenzene-1-sulfonyl)(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl}carbamate
pharmaceutical raw material
Fenproporex hydrochloride
pharmaceutical raw material
Cabazitaxel
pharmaceutical raw material
Risdiplam metabolite M1
pharmaceutical raw material
Tert-Butyl 7-(2-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)-4-oxo-4H-pyrido[1,2-a]pyrimidin-7-yl)-4,7-diazaspiro[2.5]octane-4-carboxylate
research compound
7-(4,7-diazaspiro[2.5]octan-7-yl)-2-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)pyrido[1,2-a]pyrimidin-4-one
ASKZRYGFUPSJPN-UHFFFAOYSA-N
CC1=CC(=NN2C1=NC(=C2)C)C3=CC(=O)N4C=C(C=CC4=N3)N5CCNC6(C5)CC6